|TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).||
||208||All||18 Years to 65 Years (Adult)||NCT00449644||CR011929
|June 2007||March 2010||October 2012||March 20, 2007||April 29, 2014||June 25, 2013||
|2||NCT00992069||Completed||Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers||
||37||All||18 Years to 65 Years (Adult)||NCT00992069||A5267
|December 2009||December 2010||December 2010||October 8, 2009||April 4, 2013||
† Study has passed its completion date and status has not been verified in more than two years.